Press Releases

Please click here if you wish to receive an e-mail notification regarding Alector press releases.

Jun 25, 2020
Alector Announces Publication of Preclinical and Phase 1 Data Validating Potential of AL002, a TREM2 Activating Antibody for the Treatment of Alzheimer’s Disease, in The Journal of Experimental Medicine
Mar 25, 2020
Alector Enters into a Licensing Agreement with Innovent Biologics to Develop and Commercialize AL008 in Oncology Indications in China
Mar 24, 2020
Alector Reports 2019 Fourth Quarter and Full Year Financial Results and Business Highlights
Feb 05, 2020
Alector Announces FDA Fast Track Designation Granted to AL101 for the Treatment of Patients with Frontotemporal Dementia
Feb 03, 2020
Alector Announces Closing of Public Offering of Common Stock and Full Exercise of Underwriters' Option to Purchase Additional Shares
Displaying 1 - 10 of 16